glp-1 weight loss success stories Body Image Distortion After Common With Drugs: Experts GLP-1 Agonists Weight Loss Drugs

[DOI] [PMC free article] [PubMed] [Google Scholar] 62.Luttrell L.M

Cell Death Dis 15 , 809 (2024)

For full details, refer to the original article:

Potential Benefits FDA-approved (as Vyleesi) for hypoactive sexual desire disorder (HSDD) in premenopausal women: documented efficacy in randomized controlled trials Acts centrally on the motivational and desire dimension of sexual response, addressing low libido rather than only erectile or lubrication function Effective in both men and women: studied for female HSDD (FDA-approved indication) and investigated for erectile dysfunction and low libido in men Complements PDE5 inhibitors: for men with both low desire and erectile difficulty, PT-141 addresses the central desire component while PDE5i addresses the peripheral vascular component Onset within 45 to 90 minutes of intranasal administration

GLP-1 medications work biologically to reset appetite and satiety, making the weight loss achievable and sustainable as long as the medication is continued

Insulin Resistance and Oxidative Stress in the Brain: Whats New